EUVIMEDEUVIMED entdecken
Crossref

Co-delivery of circCDR1 and temozolomide with hyaluronic acid-chitosan nanoparticles inhibits glioma progression

Changjiu Tang iD, Ye Wan, Xiaomin Zhang, Bao Zhong, Ming Zhang

General physiology and biophysics · 2025

DOI: 10.4149/gpb_2024048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General physiology and biophysics, 2025. Verfasst von Changjiu Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Jingmen People's Hospital/Jingchu University of Technology Affiliated Central Hospital, Jingmen City, Hubei, China. Hauptthemen laut MEDLINE: Temozolomide, Glioma, Chitosan, Hyaluronic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapeutic drug/gene nanoparticles (NPs) co-delivery system has great potential in tumor therapy. However, the role of circular RNA (circRNA) cerebellar degeneration-related 1 (CDR1) (circCDR1) and temozolomide (TMZ) NPs in the treatment of glioma remains unclear. circCDR1 was significantly low expressed in glioma tissues and cells. In the term of mechanism, circCDR1 could sponge miR-890 to regulate GJB6. The inhibition of circCDR1 on glioma progression could be reversed by miR-890, and the suppressive effect of miR-890 inhibitor on glioma progression also could be overturned by GJB6 silencing. CNPs could introduce TMZ and circCDR1 into glioma cells. The inhibitory effects of CNPs on glioma cell progression and tumor growth were much better than TMZ, TNPs and CNPs. Our study showed that circCDR1 could regulate the miR-890/GJB6 axis to inhibit glioma progression, and the constructed CNPs had a good inhibitory effect on glioma progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGliomaChitosanHyaluronic AcidRNA, CircularNanoparticlesBrain NeoplasmsHumansCell Line, TumorAnimalsDisease ProgressionMiceAntineoplastic Agents, AlkylatingMice, NudeMicroRNAsMale

Substanzen

TemozolomideChitosanHyaluronic AcidRNA, CircularAntineoplastic Agents, AlkylatingMicroRNAs

Autor:innen und Institutionen

  • Department of Neurosurgery, Jingmen People's Hospital/Jingchu University of Technology Affiliated Central Hospital, Jingmen City, Hubei, China.

ORCID-Profile: Changjiu Tang

Zitieren

APA

Tang, C., Wan, Y., Zhang, X., Zhong, B., & Zhang, M. (2025). Co-delivery of circCDR1 and temozolomide with hyaluronic acid-chitosan nanoparticles inhibits glioma progression. General physiology and biophysics. https://doi.org/10.4149/gpb_2024048

Vancouver

Tang C, Wan Y, Zhang X, Zhong B, Zhang M. Co-delivery of circCDR1 and temozolomide with hyaluronic acid-chitosan nanoparticles inhibits glioma progression. General physiology and biophysics. 2025. doi:10.4149/gpb_2024048

BibTeX
@article{Tang2025,
  author = {Tang, Changjiu and Wan, Ye and Zhang, Xiaomin and Zhong, Bao and Zhang, Ming},
  title = {Co-delivery of circCDR1 and temozolomide with hyaluronic acid-chitosan nanoparticles inhibits glioma progression},
  journal = {General physiology and biophysics},
  year = {2025},
  doi = {10.4149/gpb_2024048}
}
Kostenlos starten →